Eli Lilly's triple-agonist shot retatrutide hit 22.6% weight loss in two more Phase 3 trials — its fifth straight win, with an FDA filing due Q1 2027.
Skyroot's Vikram-1 just became the first privately built Indian rocket to reach orbit, making India the third nation with a private launch capability — and its builder is a $1.1B unicorn.
AMD's new Helios rack packs 72 GPUs and 31TB of memory — 50% more than Nvidia's Vera Rubin — plus a 256-core 2nm CPU, with OpenAI, Meta and Oracle already on board.
Munich's Helsing just raised $1.8 billion at an $18 billion valuation — Europe's biggest defense-tech round ever, chaired by Spotify's Daniel Ek.
London's Humanoid raised a $152M Series A at a $1.35B valuation to become Europe's first pure-play humanoid robot unicorn — two years old, and not a single robot shipped.
DeepSeek went out for about $7 billion and investors came back with at least $12 billion, in a Tencent- and CATL-led round ahead of a planned 2027 IPO.
🔥 Gigabyte Just Dropped a $400 WOLED Gaming Monitor and It Changes Everything...
The AI chip company Cerebras Systems — the most prominent challenger to Nvidia's GPU empire — hit the Nasdaq on Thursday under the ticker CBRS and...
> In 2025, startups discovered AI. In 2026, the winners figured out which tools to use and when. Here's the stack the smartest founders are runni...
Bending Spoons is buying Airtable for $1.285 billion in all cash — about 89% below the productivity startup's $11.7B pandemic-era peak, and its first deal since going public.
The FDA just approved FAYUVI, the first-ever treatment for Sanfilippo syndrome type A: a one-time gene therapy from Ultragenyx priced at $3.95 million per patient.
Adicet's off-the-shelf CAR-T put 54% of a small lupus trial into remission on a single dose. Then the stock dropped 22%.
Precision Neuroscience closed an oversubscribed $250M Series D at a ~$1B valuation, betting its surface brain implant beats drilling into tissue.
